NCT01928537 2020-06-30
Efficacy and Safety of IV Rigosertib in MDS Patients With Excess Blasts Progressing After Azacitidine or Decitabine
Traws Pharma, Inc.
Phase 3 Completed
Traws Pharma, Inc.
Traws Pharma, Inc.
Maastricht University Medical Center
H. Lee Moffitt Cancer Center and Research Institute